Pancreatic Cancer Research

ResearcherKunming University of Science and TechnologyActive in the last 2 years

Li Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2599-952X; OpenAlex author ID A5100425738. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Genetically proxied risk and protective factors for pancreatic cancer: a systematic review and meta-analysis of Mendelian randomization studies. Last author DOI 10.21037/jgo-2025-305↗
  2. A high bile acid environment promotes apoptosis and inhibits migration in pancreatic cancer. Co-author DOI 10.1080/21655979.2022.2045823↗
  3. MicroRNA targets autophagy in pancreatic cancer cells during cancer therapy. First author DOI 10.4161/auto.26463↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsushi Yamaguchi · 1 shared paper, 2025 · strength 0.27
  2. Richard J. Bold · 1 shared paper, 2025 · strength 0.27
  3. Fada Luo · 1 shared paper, 2025 · strength 0.27
  4. Somashekar Gopala Krishna · 1 shared paper, 2025 · strength 0.27
  5. Shaopu Zhu · 1 shared paper, 2022 · strength 0.17
  6. Maoming Xiong · 1 shared paper, 2022 · strength 0.17
  7. Bo Chen · 1 shared paper, 2022 · strength 0.17
  8. Zhen Chen · 1 shared paper, 2013 · strength 0.05
  9. Peng Wang · 1 shared paper, 2013 · strength 0.05
  10. Zhiqiang Meng · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.